dr kim hye son glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway Dr. Hye-Sung Kim | Department

doi: 10.1016/j.addr.2007.10.010 130 SuganyaVAnuradhaV

To address this challenge, collagen-based supplements with DPP-IV inhibitory activity have been developed to prolong the action of the two primary incretins, GLP-1 and GIP, thereby enhancing insulin secretion [155]

ROS and oxidatively modified macromolecules function as damage-associated molecular patterns (DAMPs), engaging pattern recognition receptors (PRRs) on microglia, including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to initiate inflammatory cascades (Block et al., 2007)

Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties

REFERENCES Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, et al